Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Novo Nordisk A/S (NVO) – Novo Nordisk A/S Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Novo Nordisk (NVO) trades at $44.28, down 1.03% today, with strong fundamentals including 37.2% net income margin and 71.4% ROE. Recent quarterly earnings consistently beat expectations, with Q1 2026 EPS of $1.04 surpassing the $0.87 estimate. Technical indicators show bearish momentum with key support at $43. The company maintains robust cash flow from operations of $119.1B in 2025 and recently announced a $1.28 dividend for H1-2026.
Outlook remains positive driven by Wegovy pill adoption and international expansion, though competition from Eli Lilly presents risks. Analyst consensus is bullish with 57.9% buy ratings. Key investment considerations include sustained GLP-1 market leadership versus pricing pressure and regulatory scrutiny over weight-loss drug side effects.
Read full analysis

Key Stats

  • Market Cap
    $206.93B
  • Sector
    Health
  • 3M Drawdown
    -25.58%
  • Enterprise Value
    $226.39B
  • Dividend Yield
    4.07%
  • Trading Activity
    98% Buy | 2% Sell
  • Typical Hold Time
    101 days
$44.24
52W Low: $35.29
30 Mar 2026
52W High: $81.05
12 Jun 2025

Novo Nordisk A/S (NVO) is currently valued at a market capitalization of $206.93B, with an enterprise value of $226.39B. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $81.05, highlighting its annual price range. Over the past three months, Novo Nordisk A/S has recorded a drawdown of -25.58%, reflecting recent price volatility. Novo Nordisk A/S offers a dividend yield of 4.07%, with the most recent dividend of $1.28 paid on 30 Mar 26. On average, investors hold Novo Nordisk A/S for approximately 101 days, indicating typical investor behavior on the platform.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $206.93B
  • Sector
    Health
  • 3M Drawdown
    -25.58%
  • Enterprise Value
    $226.39B
  • Dividend Yield
    4.07%
  • Trading Activity
    98% Buy | 2% Sell
  • Typical Hold Time
    101 days
$44.24
52W Low: $35.29
30 Mar 2026
52W High: $81.05
12 Jun 2025

Novo Nordisk A/S (NVO) is currently valued at a market capitalization of $206.93B, with an enterprise value of $226.39B. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $81.05, highlighting its annual price range. Over the past three months, Novo Nordisk A/S has recorded a drawdown of -25.58%, reflecting recent price volatility. Novo Nordisk A/S offers a dividend yield of 4.07%, with the most recent dividend of $1.28 paid on 30 Mar 26. On average, investors hold Novo Nordisk A/S for approximately 101 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!